Skip to main content
. Author manuscript; available in PMC: 2019 May 22.
Published in final edited form as: Vaccine. 2018 Nov 23;37(1):76–79. doi: 10.1016/j.vaccine.2018.11.038

Table 2.

Incidence rate (per 1000 person-years) and rate ratios of seizures following vaccination overall and by gestational age category, child’s age at vaccination, and vaccine received.

7 through 10 days after vaccination (risk interval)
15 through 42 days after vaccination (control interval)
Gestational age category Number of children Number of seizures Incidence ratea (95% CI) Number of seizures Incidence ratea (95% CI) IRR (95% CI)b Preterm vs full-term, ratio of IRR (95% CI), p
Overall
Preterm (<37 weeks) 45,343 31 62 (42–89) 56 16 (12–21) 3.9 (2.5–6.0) 1.2 (0.76–1.9), 0.41
<35 weeks 16,586 10 55 (26–100) 22 17 (11–26) 3.2 (1.5–6.7) 1.0 (0.47–2.1), 0.99
35–36 weeks 28,757 21 67 (41–100) 34 15 (11–22) 4.3 (2.5–7.4) 1.4 (0.77–2.4), 0.29
Full-term (≥37 weeks) 487,032 232 43 (38–49) 510 14 (12–15) 3.2 (2.7–3.7)
Vaccine received
MMR
  Preterm 37,262 22 54 (34–82) 48 17 (12–22) 3.2 (1.9–5.3) 1.2 (0.70–2.0), 0.51
  Full-term 403,238 163 37 (31–43) 425 14 (12–15) 2.7 (2.2–3.2)
MMRV
  Preterm 8081 9 100 (47–190) 8 13 (5.6–25) 7.9 (3.0–20) 1.4 (0.51–3.8), 0.52
  Full-term 83,794 69 76 (59–95) 85 13 (11–16) 5.7 (4.1–7.8)
Child’s age at vaccination
12–15 months
  Preterm 41,391 27 60 (39–87) 51 16 (12–21) 3.7 (2.3–5.9) 1.3 (0.77–2.1), 0.36
  Full-term 442,919 200 41 (36–47) 477 14 (13–15) 2.9 (2.5–3.5)
16–23 months
  Preterm 3952 4 92 (25–237) 5 17 (5.4–39) 5.6 (1.5–21) 0.82 (0.20–3.4), 0.79
  Full-term 44,113 32 66 (45–94) 33 10 (6.7–14) 6.8 (4.2–11)

Abbreviations: MMR, measles-mumps-rubella; MMRV, measles-mumps-rubella-varicella; IRR: incident rate ratio, CI, confidence interval.

a

Per 1000 person-years.

b

IRR (7–10 days versus 15–42 days after vaccination).